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ABSTRACT The adhesive and hemodynamic forces that lead to lymphocyte rolling and arrest on activated endothelium and
the biophysical role of various adhesion molecules and blood elements in this process are poorly understood. By quantifying
their behavior both in vivo and in vitro, we show here that erythrocytes facilitate selectin- and integrin-mediated rolling and
binding of T-lymphocytes on tumor necrosis factor a-activated endothelium. The relative contribution of selectins and
integrins to this process can be distinguished by using a simple mathematical expression of lymphocyte capture within the
range of physiological shear stress. The need for selectin participation in lymphocyte capture increases with shear stress (>1
dyn/cm2), and both ,B1 and ,B2 integrins act in synergy to produce adhesive drag on captured cells. These findings are
potentially useful in developing strategies for intervening with T-cells in a variety of normal and pathological responses as well
as for the delivery of genetically modified T-cells to their targets in vivo.
INTRODUCTION
When a blood-borne leukocyte comes in contact with the
vessel wall in vivo, it may continue to move with the flow
stream, may roll on the endothelium, or may attach tran-
siently or permanently to the endothelium and extravasate
(Lawrence and Springer, 1991; Ley et al., 1991; von
Andrian et al., 1991). The outcome of this interaction de-
pends on the balance between adhesive forces exerted by
cellular adhesion molecules (CAMs) and hydrodynamic
forces generated by the blood (Hammer and Apte, 1992).
Recent in vitro and in vivo studies have focused on the role
of two types of CAMs in leukocyte rolling and arrest:
selectins (Bevilacqua et al., 1987; Geng et al., 1990; Kansas
et al., 1993; Larsen et al., 1989) and integrins (Bevilacqua,
1993; Hakkert et al., 1991; Springer, 1990; Hession et al.,
1992). These studies have led to a paradigm in which
selectins mediate rolling whereas integrins produce cell
arrest (Hammer and Lauffenburger, 1987; Lawrence and
Springer, 1991; Ley et al., 1991; von Andrian et al., 1991).
The biophysical basis of this paradigm as applied to lym-
phocytes is not known. Both integrins and selectins have
been shown to be important in the recirculation and local-
ization of lymphocytes (Tamatani et al., 1993; Tamatani
et al., 1991).
Previous studies of lymphocyte interaction with vascular
endothelium have established a probabilistic view of lym-
phocyte adhesion (Bjerknes et al., 1985) and have shown
that lymphocytes may roll on the endothelium under some
circumstances (Berg et al., 1993). In addition, some studies
(Nobis et al., 1985; Schmid-Schonbein, 1987; Schmid-
Schonbein et al., 1980) have suggested that erythrocytes
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may contribute to the forces influencing leukocyte interac-
tions with the vascular endothelium; however, the extent to
which this influences the outcome of these interactions is
not clear. Because T-lymphocytes are involved in a wide
variety of normal and pathological responses and can be
used as vectors for gene therapy, we designed the present in
vivo-in vitro study to answer the following questions:
1) Under what conditions do lymphocytes roll and adhere to
activated endothelial cells? 2) What is the role of various
CAMs alone or in combination in this process? 3) Do
erythrocytes (RBCs) play any role in lymphocyte adhesion?
We have selected both in vitro and in vivo methods to
investigate this phenomenon. A parallel plate flow cell was
employed to examine the kinetics and mechanics of lym-
phocyte binding to activated endothelial cells in vitro and
compared to the interaction of lymphocytes with activated
endothelial cells in vivo in the dorsal skin of mice. We
report here a quantitative description of the role of various
CAMs in lymphocyte adhesion and describe the influence
of erythrocytes on this process.
MATERIALS AND METHODS
Preparation of human lymphocytes
Human T-cells obtained from leukapheresis of normal platelet donors were
isolated by Ficoll-Hypaque centrifugation followed by depletion of the
B-cell, natural killer cell, and monocyte populations using antibodies
directed against CD19 (clone J4.119; AMAC, Westbrook, ME), CD16
(B73.1; Becton-Dickinson, San Jose, CA), and CD15 (clone MMA; Bec-
ton-Dickenson) at 10 jig antibody/15 X 106 cells, followed by adsorption
to a paramagnetic substrate for 30 min (Advanced Magnetics, Cambridge,
MA) and removal by a magnetic field. The lymphocytes isolated from this
procedure were typically 72% CD4+ and 28% CD8+ cells by flow cyto-
metric analysis. The cells were labeled for fluorescence microscopy with
0.01 mM calcein (Weston and Parish, 1990, 1992) in PBS for 15 min,
washed, and resuspended in Hanks' balanced salt solution (HBSS) (with
Ca2' and Mg2+) for injection i.v. into SCID mice (100 ,ul cells in PBS) or
used in the in vitro flow chamber with erythrocytes. Cells used for in vitro
experiments without RBCs were not labeled.
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In vivo methods
Dorsal skin chamber implantation was performed under anesthesia with
ketamine (9 mg/100 g body weight) and xylazine (0.9 mg/100 g body
weight) (Leunig et al., 1992). The interaction of blood cells with the
vasculature of the dorsal skin was observed through the transparent win-
dow of the chamber. Implanted dorsal chambers were activated with tumor
necrosis factor a (TNF-a) by direct superfusion into the dorsal window (50
ng in 10 ,ul PBS; Cetus/Chiron, Emeryville, CA) for 5 h before cell
injection. Cells (30-40 million) were injected over a period of 30 s, and the
arrival of cells in the vessels of the chamber was monitored by fluorescence
video-microscopy and recorded. Antibody blocking studies were done by
incubating the cells with 10 jig of antibody for 30 min at 4°C before
injection using 1) anti-CD49d (clone HP2/1; AMAC, Inc.), 2) anti-CD18
(clone IB4 obtained from Karl Arfors), 3) anti-L-selectin (clone Dreg 56;
AMAC). All antibody blocking studies were limited to 5 min after the
injection of cells to avoid shedding of the bound antibody, and observations
of each section of vessel were limited to 30 s periods. Blood velocities
were determined by the i.v. injection of 1-Am-diameter fluorescent
latex spheres (5 X 108 in 50 j,l PBS), and the mean of the top three
velocities determined from direct measurement of "on screen" images
was used to approximate the flow velocity. Relative wall shear stress
was approximated by assuming a 32% hematocrit in these vessels with
a corresponding viscosity (Chien et al., 1984). The percentage of rolling
and binding cells was determined as a fraction of all cells observed in
a 200-,um section of vessel for a 30-s period between 2 and 5 min after
the injection of cells. A cell that maintained stable arrest for at least 5
s was considered bound.
TABLE I Flow parameters for in vitro experiments
Flow rate Shear stress* Time to steady Total flow time§
(ml/min) (dynes/cm2) statet (s)
2.0 4.04 104 129
1.5 3.06 90 115
1.0 2.02 92 117
0.8 1.63 91 116
0.6 1.23 93 118
0.4 0.82 98 123
0.2 0.41 118 143
Experiments were started at a high flow rate, then decreased with time
according to a protocol designed to deliver equal flux at each flow rate. The
initial flow period at 0.2 ml/min was selected so that the delivered flux just
reaches steady state before data collection commences. The remaining flow
times were calculated (Munn et al., 1994) by equalizing the total number
of cells, Gi, passing at each step according to
Cx tUi_i 2vx / vx\ x\Gi = t-+ h + 1J + cui t1 + hytwi - -
where ui and ui l are the current and previous velocities, respectively, and
twi is the time spent at flow rate i (including sampling time).
*Shear stress was calculated assuming a viscosity of 0.0089P.
tTime required after the change of flow rate to re-establish steady-state
flux condition.
§ Observation time + time to steady state.
Flow cell measurements
T-cells isolated from normal human donors were perfused over TNF-a-
activated 2° HUVEC monolayers with HBSS in a parallel plate flow cell,
as previously described (Munn et al., 1994). The bulk cell concentration
was 1 x 106 cells/ml in all in vitro experiments. Each flow experiment was
started at high wall shear stress (4.1 dyn/cm2), then the flow rate was
decreased in steps, and the cumulative bound cell density was determined
at five fields with the 1OX objective at each level of shear stress. The time
interval at each flow step was adjusted so that the total number of cells
delivered to the surface is constant for each shear stress level (Table 1)
(Munn et al., 1994). Antibody blocking of individual and multiple CAMs
was used to evaluate their participation in the lymphocyte capture process.
Antibodies used in these studies were as follows: a) anti-CD49d (clone
HP2/1), b) anti-CD18 (clone IB4), c) anti-L-selectin (clone Dreg 56), d)
anti-CD2 (clone S5.2, anti-Leu-5b; Becton-Dickinson, Inc.), e) anti-E
selectin (clone H18/7; Becton-Dickinson), f) anti-VCAM-1 (clone lGll;
AMAC), g) anti-ICAM-1 (CD54, clone 84H10; AMAC). Antibody treat-
ment of the lymphocytes was done with 10 ,ug antibody/15 X 106 cells
(antibody excess by staining), and the HUVEC monolayers were treated
with 10 jig antibody in 0.5 ml culture medium.
In individual experiments, the number of bound cells per field was
determined for five adjacent fields for each level of shear stress, and the
mean values were used to calculate the individual binding density. Varia-
tion in cell number for adjacent fields was generally less than ± 15% of the
mean. A minimum of four independent experiments were combined for
each treatment to produce a mean and standard deviation for each binding
density shown. Rolling velocities were determined from direct measure-
ment of on-screen images over several frames.
Calculation of capture efficiencies
In vitro capture efficiencies were calculated from the binding densities in
each treatment group. A capture event was defined as a stable arrest of a
cell from the flow stream for at least 5 s. Because the cell flux at the surface
of the flow chamber varies with the flow rate (shear stress), the time
interval at each flow step was adjusted so that the total number of cells
delivered to the surface was constant for each shear stress level (Munn
et al., 1994). This normalization permitted us to calculate a capture effi-
ciency defined as the number of cells that bind (Nb) at a given shear stress
divided by the total number of cells (N1) that have passed near the surface
(E = Nb/Nt). The cumulative binding curves are fit to the equation
Nb/Nt = E.e-KS, where S is the shear stress, and Eo and K are adjustable
parameters (this equation fit the data well, with R2 greater than 0.95 in all
cases). The value of Eo was then calculated from E. = Eo[1 - e-KAS
where AS is the difference in shear stress values for successive steps. Thus,
E = Eoe-KS. This process was performed for each of the antibody treat-
ment and control groups, and the resulting function was plotted. Differ-
ences in the resulting parameters, K and E., were compared between
various treatment groups with the t-test and Mann-Whitney test.
Flow cell measurements with RBCs
Experiments were conducted in vitro with reconstituted blood [calcein-
labeled T-cells and RBCs at 32% hematocrit based upon 40-100 J,m
vessel size (Chien et al., 1984)] perfused through the parallel plate flow
chamber (Munn et al., 1994). Reconstituted blood was prepared by Ficoll-
Hypaque gradient separation of RBCs from mononuclear cells followed by
repeated washing in PBS. RBCs were resuspended in HBSS or fetal bovine
serum, and calcein-AM-labeled lymphocytes were added to a concentration
of 1 X 106 cells/ml. T-cells suspended in HBSS or 32% hematocrit in
HBSS were perfused through the flow chamber at constant shear stresses
of 1.1, 2.3, or 4.6 dyn/cm2 for 5 min. Ten fields were then sampled and the
numbers of rolling and firmly attached cells (adherent for at least 5 s) were
counted. The rolling fraction (i.e., the number of rolling cells divided by
total cells bound and rolling) and the capture efficiency (i.e., the number of
bound cells divided by the number of cells passing the surface during the
5-min flow period) were determined. Rolling fractions shown are the mean
± SD of four independent experiments. For the normalization, the viscos-
ities of the RBC solutions were estimated using the equation of Quemada
(Chien et al., 1984) and verified by direct measurement of pressure drop
across the flow chamber.
Successive images of rolling cells, both in vitro and in vivo, forming
composite photographs, were captured 1 s apart and combined by image
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addition, then processed using a despeckling filter and a S X 5 gradient
convolution.
RESULTS AND DISCUSSION
Lymphocyte rolling and arrest in vivo
The characteristics of in vivo interaction of lymphocytes
with TNF-a-activated endothelium were evaluated in the
mouse dorsal skin chamber model. We injected calcein-
labeled human T-lymphocytes into SCID mice and ob-
served their interaction with vessels of the dorsal skin
through the surgically implanted transparent window
(Leunig et al., 1992). Five hours before the tail vein injec-
tion of fluorescent lymphocytes, the vessels within the
chamber were activated with TNF-a. This time period was
sufficient to activate endothelial cells and to initiate the
capture of passing lymphocytes (Bevilacqua et al., 1989;
Yan et al., 1994). Within 30 s the injected cells could be
observed entering the arterioles in the skin chamber, and by
1 min they could be observed in both the post-capillary
venules and the 50-100-p.m-diameter collecting venules.
Upon entering these vessels, over 30% of the total cells
observed in the collecting venules (approximately 90% of
all cells contacting the vessel walls) were observed to roll
along the wall of the venules with a velocity of approxi-
mately 20 ,um/s (Table 2). Rolling was observed over dis-
tances of 40-200 p.m and was interrupted with jumps of
50-100 p.m. Some rolling cells were observed to halt and
adhere to the vessel wall; the duration of the adhesion was
5 to 10 s in the large venules and several minutes or longer
in the post-capillary venules. The range of wall shear stress
in these larger vessels, based on the measurement of the
flow velocities, was between 1.2 and 3.0 dyn/cm2.
We then attempted to reduce rolling and arrest of lym-
phocytes by anti-CAM antibodies in a manner similar to
that of neutrophils (von Andrian et al., 1991). Treatment of
the T-lymphocytes with antibodies against LFA-1 (CD18)
or VLA-4 (CD49d) produced a significant reduction in the
number of cells rolling on and binding to the vessel walls
(Table 2). The greatest reduction in rolling and binding cells
was seen after blocking by both anti-CD18 and anti-VLA-4.
Thus, adhesion mediated by CD18/ICAM-1 and VLA-4/
VCAM-1 appears to function in a complementary manner.
In addition, blocking the L-selectin on the lymphocytes also
resulted in reduced numbers of rolling and binding cells. In
contrast, treatment with anti-CD2 antibody did not produce
a significant decrease in the number of rolling or adhering
cells. Quantification of the velocities of cells that could roll
after these treatments indicated that the cells treated with
anti-L-selectin antibody had unchanged rolling velocities
but those treated with anti-VLA-4 and anti-CD18 rolled at a
significantly increased rate (Table 2), indicating that the
adhesive drag on these lymphocytes was reduced by block-
ing the integrins. This further suggested that the reduction in
number of rolling cells observed after selectin blocking was
due to reduced efficiency of initial lymphocyte capture, but
the reduction in rolling cells that followed integrin blocking
may be due to the decrease in the adhesive force that
maintains cell contact under dynamic conditions.
Lymphocyte behavior in vitro
The mechanism of lymphocyte adhesion may be influenced
by the flow environment. Because it is difficult to precisely
modulate shear rates in vivo, we employed a parallel plate
flow chamber to quantify the rolling and arrest of cells on
endothelial monolayers under defined shear stress (Law-
rence et al., 1987, 1990; Lawrence and Springer, 1991;
Munn et al., 1994). As in our in vivo experiments, the
endothelial cells were activated with TNF-a and T-cells
were introduced into the flow chamber (Munn et al., 1994).
Shear stress was initiated at 4.1 dyn/cm2 and subsequently
reduced in seven steps to 0.4 dyn/cm2, and the number of
bound cells was quantified at each step. Adhesion was
defined as stable arrest for at least 5 s. Lymphocyte accu-
mulation was not observed on nonactivated endothelium;
however, the arrest of lymphocytes on TNF-a-activated
endothelium increased significantly (p < 0.05) between 2
and 5 h after stimulation (Fig. 1 A).
To test the hypothesis that various CAMs contribute to
different degrees to the net adhesive force at different levels
of shear stress, we blocked various CAMs with monoclonal
antibodies and evaluated the changes in the binding curve of
the treated as compared to control cells over a range of
physiological shear stresses. In these in vitro experiments,
pretreatment of the T-lymphocytes with anti-LFA-1 anti-
TABLE 2 Effect of antibody blocking of L-selectin or integnns on T-cell rolling and binding in vivo
Rolling velocity Shear stress
Treatment % rolling % binding (,m/s) (dyn/cm2)
Isotype control (N = 4, n = 10)* 34.1 ± 12.3 8.8 ± 3.5 19.0 ± 16.5 2.9 ± 1.5
L-selectin (N = 4, n = 6) 12.1 ± 3.9* 3.0 ± 2.5t 23.7 ± 13.5 2.0 ± 0.8
VLA4+CD18 (N = 4, n = 6) 7.1 ± 2.9*§ 1.4 ± 1.3t 64.4 ± 17.8t 1.7 ± 0.7
VLA4 (N = 4, n = 7) 11.8 ± 3.2*§ 2.5 ± 2.2t 53.7 ± 25.8t 1.2 ± 0.3
CD18 (N = 4, n = 6) 18.6 ± 8.8*5 2.7 ± 1.0* 47.3 ± 21.7t 1.7 ± 0.3
*The number of mice and vessels observed are indicated as N and n, respectively. Mean values ± SD are shown for N.
tSignificant difference from control, p < 0.05
6Significant difference between single and double antibody groups, p < 0.05.
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A synergistic reduction in cell binding, significantly less than
TNF-a activation Experimental Time LFA-1, VLA-4, ICAM-1, or VCAM-1 alone (p < 0.01, Fig.
1.75 b 1 D). Treatment of the lymphocytes with an antibody di-
Z60 h rected against CD2 did not produce a significant change in
the number of adherent cells in vitro (not shown). To
examine the role of selectins, we also used anti-L and
0.41 0.82 1.2 1.6 2 31 41 E-selectin antibodies (Fig. 1 E). These experiments showed
B c significant (p < 0.05) reductions in the number of bound
T I t cells at shear stresses from 0.4 to 2 dyn/cm2.
1.2 1.6 2 3.1 4.1 0.41 0.82 1.2 1.6 2 3.1 4.1
Wall Shear Stress (dyn/cm2)
FIGURE 1 In vitro cell capture in the parallel plate flow chamber. A
quantitative analysis of the kinetics of lymphocyte adhesion to activated
endothelium as well as the contribution of various selectins and integrins to
the process of lymphocyte capture on TNF-a-activated endothelium was
conducted. Endothelial cell monolayers were activated with TNF-a for
various time intervals and installed in the parallel plate flow chamber.
T-lymphocytes suspended in the flow solution were perfused through the
chamber at different flow rates, thus generating a range of physiological
shear stress levels. Flowing cells were observed for stable arrest, defined
by adhesion to the endothelium for at least 5 s. Because optimal lympho-
cyte adhesion was observed between 5.5 and 8 h after endothelial activa-
tion (A), subsequent mechanistic studies were conducted within this time
interval. Expression of ICAM-1, VCAM-1, and E-selectin was strongly
indicated by immunofluorescent staining of the monolayers during this
time period (not shown). Blocking various adhesion molecules with mono-
clonal antibodies permitted a dissection of the adhesion process. The
symmetry of the blocking effect was examined by using antibodies against
either the lymphocyte or the endothelial side of the interactions. (B-E)
Results of antibody blocking (averaged from four experiments each) on the
cumulative bound cell density for TNF-a-activated monolayers. All treat-
ments are compared with irrelevant IgG control antibody averaged from 11
experiments (solid bars). Significance is indicated at p < 0.05 (*) or p <
0.01 (t), and the error bars represent one standard deviation. Treatment
with a combination of CD18 + VLA4 or ICAM-1 + VCAM-1 resulted in
a dramatic and synergistic reduction in the number of binding cells.
body did not result in a significant reduction of the number
of binding cells at 0.4 to 2.0 dyn/cm2 when compared to
lymphocytes treated with an irrelevant control antibody
(Fig. 1 B). Treating the endothelial cells with anti-ICAM-1
also showed little effect on lymphocyte binding at shear
stress levels lower than 2 dyn/cm2. Blocking of VLA-4 or
VCAM-1 produced significant reductions in binding across
the range of shear stresses tested (Fig. 1 C). However,
simultaneously blocking both LFA-1 and VLA-4 or their
ligands, ICAM-1 and VCAM-1, produced a dramatic and
Relative contributions of CAMs
Because the observed number of bound cells in these ex-
periments represents the accumulation of cells at multiple
levels of shear stress within a physiological range, the
change in bound cell density with changing shear stress is
directly related to the binding efficiency as a function of the
detachment force generated by the flow. Therefore, to quan-
tify the relative contributions of various CAMs alone or
together and to facilitate their comparison, we fit the bind-
ing data to the following equation: E = Eoe-KS, where E is
the capture efficiency at shear stress S, E. is the zero shear
efficiency, and K is the capture coefficient. The parameter K
describes the relative sensitivity of lymphocyte capture to
shear stress and must therefore be a function of the reaction
rate and bond strength because the force placed on the initial
bond is linear with increasing shear stress (Alon et al.,
1995). In the case of TNF-a activation of the endothelium,
K is determined by the cooperation of various molecules
acting in concert to produce a transient arrest that can lead
to stable, long-term adhesion. As the efficiency of capture
increases, K will decrease. In practical terms, this indicates
that a high adhesive force at the time of contact will permit
relatively little decrease in the capture efficiency with in-
creasing shear stress. Consequently, molecules with a rapid
kf such as P-selectin (1.5 X 107 s-1; Alon et al., 1995) will
have a dominant effect at high flow rates, especially if
present in high concentration.
E. provides a relative index of the efficiency of the
adhesion process after initial capture, over a range of shear
stress levels, and reflects the stability of the adhesion com-
plex. In this setting, the stable adherent cell utilizes multiple
molecular species to maintain adhesion and iesist detach-
ment, reflecting ligand-receptor affinity and concentration.
Thus, blocking integrin-mediated interactions decreases the
net adhesive force and may permit cells to roll via selectin
interactions (rolling is not considered to be a stable adhesion
event for the purpose of quantification in these studies) or
detach. Eo thus provides a functionally useful means of
comparing the relative net adhesive force between different
cell populations and activated endothelium.
We found reproducible differences in Eo and K for various
antibody treatments of lymphocytes or HUVECs (Fig. 2, A and
B). There was no significant reduction in Eo for anti-VLA-4 or
anti-VCAM-1 antibodies alone; however, a significant reduc-
tion in Eo (p < 0.05) was obtained with the addition of
antibodies to VCAM-1 and ICAM-1 simultaneously, from
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FIGURE 2 Comparison of binding efficiencies. Lymphocyte binding
data were fit to a mathematical model to define separate components of the
adhesion process. (A) Typical cumulative curve from experimental data
obtained in Fig. 2. These plots were then fit to a two-parameter exponential
equation (see Materials and Methods), in which the slope of the resulting
line (K) reflects the efficiency of lymphocyte capture as a function of the
shear stress. Together with the second parameter (EO), a binding efficiency,
E, may be calculated for any given shear stress. (B) Comparison of the
resultant binding efficiency curves obtained in this manner for various
antibody treatments over the range of shear stresses considered. Antibody
blocking can alter the efficiency plots by changing the slope of the line, its
relative position along the y axis, or both. Blocking either VCAM or a
combination of VCAM-1 + ICAM-1 results in a downward shift of the
efficiency plot; however, blocking either L- or E-selectin principally changes
the slope of the line (i.e., the efficiency of lymphocyte capture at different
levels of shear stress). The significant change in the slope (K) of the capture
efficiency plot for the anti-L- and E-selectin treatment indicates that these
molecules are more important at the higher shear stresses (C). Significant
differences (p < 0.05) compared to IgG control are marked with an asterisk.
0.015 ± 0.003 (control) to 0.004 0.001 (antibody treatment).
In contrast, blocking of L- and E-selectins significantly af-
fected K (Fig. 2 C, p < 0.05) but not E., indicating that these
molecules are more important at higher shear stresses, where K
has the greatest influence. The effect of combined blocking of
selectin and 11 integrin interactions on the parameter values
was inconclusive because of extremely low numbers of arrest-
ing cells at shear stress levels over 2 dynes/cm2. However, the
contribution of the selectins to T-lymphocyte adhesion appears
to be fundamentally different from that of the integrins, per-
haps because of different molecular binding kinetics, as previ-
ously suggested (Lawrence and Springer, 1991; Dembo et al.,
1988; Jones et al., 1994), and depends on the shear stress.
The in vitro findings provide a quantitative justification of
the hypothesis that selectins decelerate passing lymphocytes,
allowing the integrins to generate adhesive drag, similar to the
model proposed for the neutrophil system (Lawrence and
Springer, 1991; Ley et al., 1991; von Andrian et al., 1991).
However, our work with lymphocyte adhesion indicates that
the VCAM-1/VLA-4 interactions play a central role in the
initial contact between T-cells and activated endothelium,
which is then reinforced by stabilization of the adhesion by
ICAM-1/LFA-1. Such a system would help to explain why
anti-ICAM-1/LFA-1 treatment alone was unable to produce a
significant reduction in T-cell adhesion in vitro but was still
able to produce strong synergy with the anti-VCAM-1/VLA-4
treatment. It is notable, however, that anti-LFA-1 treatment
reduced the frequency of cell rolling and binding in vivo,
possibly reflecting a difference in the types of endothelium
being tested and the amount of ICAM-1 expressed. Selectins
appear to fill the role of mediator of the initial interaction,
especially at high shear stresses and under conditions of low
VCAM-1 and ICAM-1 expression. This is supported by the
rapid decrease of in vitro capture efficiency after L- or E-
selectin blocking seen at the high shear stresses (reflected by
high K), where selectins may facilitate the subsequent integrin-
dependent interactions.
Recent work (Alon et al., 1995) has shown that tethering of
neutrophils to P-selectin in vitro is likely to be a quantum
event, with a single bond being sufficient to initiate attachment
of a cell from the flow in a monotonic system. However, a
system containing at least three different adhesion-mediating
species of molecules will produce a net adhesive force that is
proportional to the relative concentration and reaction rates of
each ligand-receptor pair. As a result, the subtraction of the
L-selectin contribution to the net force may not be noticeable
as a change in rolling velocity (Table 2), but could still produce
a significant decrease in the efficiency of the initial capture
event. Furthermore, it is unlikely that only L-selectin is in-
volved in the initial capture and rolling events. E- and P-
selectin (Luscinskas et al., 1995) can potentially interact with
other ligands on the surface of leukocytes, such as PSGL-1
(Moore et al., 1994). Because these molecules are also up-
regulated on TNF-a-activated endothelium, they may also
contribute to the capture and rolling of passing lymphocytes in
this system, as indicated by the in vitro blocking experiments
with anti-E selectin.
Differences between in vivo and
in vitro observations
Striking differences were seen in the behavior of the T-cells in
the flow chamber versus the mouse skin vasculature. Under
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our activation protocol in vitro, most T-cells did not sponta-
neously roll on the monolayer. The attachment of T-lympho-
cytes to the endothelial monolayers proceeded rapidly after the
initial contact. In general, cells contacting the surface arrested
in less than one revolution with rare rolling cells, although
some cells detached from the monolayer and reattached at
some point downstream. Rolling of lymphocytes across the
monolayer could be increased, however, if the lymphocytes
were allowed to make initial contact under conditions of low
shear stress followed by a gradual increase in shear stress.
Increasing the shear stress from 2 to 14 dyn/cm2 in steps of 1
dyn/cm2 after the arrest of the lymphocytes at low shear stress
resulted in approximately 33% loss in bound cells (2.75% cell
loss/dyn/cm2). Once the cells were observed to roll and detach
from the monolayer during the first minute of increased shear
stress, no further cell detachment could be observed until the
shear stress was again increased, suggesting a narrow "win-
dow" of permissive conditions for rolling to occur in this
setting. Under these conditions, a few cells in each field would
roll slowly at velocities ranging from 7.8 ± 3.5 ,um/s at 1.8
dyn/cm2 to 9.9 ± 4.4 ,um/s at 14 dyn/cm2, until they moved
out of the field or detached from the monolayer. This is in
contrast with the events in vivo, where rolling and frequent
transient attachment to the vessel wall were the dominant
forms of interaction.
These differences between in vivo and in vitro studies point
to several interesting features of lymphocyte-endothelial inter-
action. Lymphocytes can roll over TNF-a-activated endothe-
lium; however, the process by which this occurs appears to be
different in vitro from that in vivo. In vitro rolling required the
lymphocytes to establish some level of firm adhesion to the
endothelium before the application of shear stress. Without this
provision, most cells (96%) would quickly detach from the
monolayer without rolling or simply maintain firm adhesion as
long as the shear stress was constant. The fact that such
behavior was generally not observed in vivo within the vessel
sizes observed (Fig. 3 A) suggests the involvement of other
forces in the vicinity of the vessel wall. We hypothesized that
a normal force contribution from the erythrocytes (RBCs)
helps to maintain contact between the lymphocytes and the
endothelium, as suggested for other leukocytes (Nobis et al.,
1985; Schmid-Schonbein, 1987; Schmid-Schonbein et al.,
1975, 1980). To test this hypothesis, we prepared platelet-free
blood with only the T-lymphocyte populations at a 32% he-
matocrit (Chien et al., 1984) and tested the effect of the
modified flow medium on lymphocyte capture in vitro (Fig. 3,
B and C). The total number of lymphocytes delivered to the
monolayer decreased as a consequence of the decreased sedi-
mentation rate of the lymphocytes, which was in agreement
with our theoretical predictions (Munn et al., 1994), but the
efficiency of cell capture approximately doubled at moderate
shear stresses with the addition of erythrocytes. Lymphocyte
capture was rare at over 4 dyn/cm2 without RBCs in the flow
medium (Fig. 3 C). The addition of RBCs also increased the
fraction of rolling cells versus adherent cells, and rolling ve-
locities were comparable to those measured in vivo (Table 2).
Because in vitro flow velocities were based on estimates of
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FIGURE 3 Human T-cell rolling in vivo and in vitro in the presence of
RBCs. The lack of similarity in the characteristic behavior of lymphocytes
on activated endothelium in the parallel plate flow cell and in the venules
of the skin prompted an examination of the role of RBCs in the process of
lymphocyte rolling, capture, and adhesion. (A) Composite image of cells
rolling along the vessel wall at 1-s intervals. The images of individual
rolling cells are highlighted with a white line, and intermittent jumps are
indicated with a black arrow. Variation in the spacing between cell images
in the same line reflects changes in rolling velocity. The venule appears as
a dark background extending across the field. (B) Simulation of this event
in vitro after the addition of RBCs to the flow medium at a hematocrit
comparable to the observed venules. Approximately 20% of the fluores-
cently labeled lymphocytes were observed to roll over the endothelial cells.
Rolling cells appear as in (A) and demonstrate similar velocity variations.
(C) The increase in the fraction of rolling cells in the presence of RBCs in
vitro. Flow rates were adjusted to produce equal shear stresses, with and
without RBCs, assuming bulk viscosities of 2.4 cP (1.1 dynes/cm2), 2.2 cP
(2.3 dynes/cm2) and 1.95 cP (4.6 dynes/cm2). The efficiency of cell
capture approximately doubled at moderate shear stresses with the
addition of erythrocytes and could not be observed at all over 4 dyn/cm2
without RBCs in the flow medium. The addition of RBCs also increased
the fraction of rolling cells versus adherent cells, with 15-30% of the
lymphocytes observed to roll over the endothelial cells at 32 ± 26 ,um/s
(2.3 dyn/cm2), which is comparable to the rolling velocities observed in
vivo (Table 2).
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bulk viscosity of the flow medium and the cell free layer near
the endothelial cells may have a lower viscosity than the bulk
estimate, the increase in cell binding might be explained by
decreased wall shear stress due to lower flow rates used with
the RBC containing suspensions. This is unlikely, however,
because experiments performed using equal flow rates for both
RBC-containing and RBC-free suspensions produced signifi-
cantly higher lymphocyte binding in the RBC-supplemented
solutions (unpublished observations).
Similar to the behavior in vivo, cells that detached from
the monolayer while rolling frequently reattached a short
distance downstream, an event that was only rarely ob-
served in RBC-free experiments. Furthermore, the com-
bined effects of anti-LFA-1 and VLA-4 treatment in vivo
(Table 2), and in vitro with added RBCs (not shown) did not
demonstrate the synergistic effect seen in vitro without
RBCs, suggesting that the presence of RBCs in vivo may
have masked the effect by promoting reattachment of dis-
lodged lymphocytes. In addition, the in vitro rolling veloc-
ities increased to 32 ± 26 ,um/s at 2.3 dynes/cm2, which
was not significantly different from the observed in vivo
rolling velocities. Thus, these observations suggest that
RBCs provide a critical function in maintaining lymphocyte
contact with the endothelium and by increasing the fre-
quency of lymphocyte capture.
Two principal mechanisms may be considered with re-
gard to the enhancement effect of RBCs in the flow stream.
First is the segregation of RBCs by radial migration in
Poiseuille flow, which is associated with RBC deformation
(Goldsmith and Spain, 1984; Karnis and Mason, 1966).
Because RBCs are considerably more deformable than leu-
kocytes, this effect would not be expected to influence
leukocyte distribution directly (Schmid-Sch6nbein et al.,
1981). This could potentially lead to an increased lympho-
cyte flux in the vicinity of the endothelium, resulting in
increased.interaction. However, direct observation of the
number of passing cells within the flow chamber was unable
to demonstrate an increase in the cell flux near the wall. An
alternative mechanism is the outward dispersive effect of
RBCs produced by cell interactions at physiological hema-
tocrits (Goldsmith and Spain, 1984) during flow in a narrow
tube. The random lateral displacements of RBCs may pro-
duce repeated collisions with lymphocytes located near the
wall and consequently promote increased lymphocyte-wall
collisions. If the distribution of adhesion molecules on the
wall is heterogeneous, this would result in 1) an increased
probability of encountering a favorable binding site and 2)
a greater, sustained, normal force upon the rolling cells than
would result from adhesion dependent torque alone.
Revised paradigm for lymphocyte-
endothelial interaction
The likely sequence of events leading to lymphocyte attach-
ment appears to be initiated by RBCs promoting lympho-
mediated deceleration (especially at high shear stress), then
VLA-4/VCAM-1-mediated adhesion and reinforcement of
adhesion by LFA-1/ICAM-1. However, the degree of in-
volvement of any particular CAM in this sequence may be
the result of a rate-limiting process of molecular binding
(Dembo et al., 1988). Consequently, our findings suggest
that CAM involvement in lymphocyte capture is dependent
on the shear rate for given ligand concentrations. The effect
of the CD18-mediated interactions on lymphocyte rolling
may be to generate additional adhesive drag on slowly
moving cells. Although CD18 may not directly mediate
rolling interactions (Alon et al., 1995), it may be able to
augment adhesion once established by more kinetically
favored molecules. VLA4-VCAM interactions are likely to
function in a similar manner at higher shear rates. Other
studies that have examined the heterogeneity of CAM ex-
pression on the surface of TNF-a-activated HUVEC cells
using a quantitative imaging technique have shown wide
variations in the expression of ICAM-1 and VCAM-1 on the
surface of activated HUVECs. Localization of captured
T-cells from the flow cell experiments coincides with in-
creased levels of expression of these molecules (Munn
et al., in press). This supports the concept that increased
adhesive drag from 131 and (32 integrins decelerates and
immobilizes passing cells and that variations in expression
on the monolayer may account for the detailed behavior of
the rolling lymphocytes.
The role of RBCs in the process of attachment is manifested
in at least three ways. First, the overall efficiency of lympho-
cyte capture over a range of physiological shear stresses is
enhanced. Second, the "permissive window" of conditions for
rolling is increased, because a RBC normal force adds to the
initial adhesive force (and torque-induced normal force;
Schmid-Schonbein et al., 1975) to facilitate lymphocyte
contact. Third, the RBCs aid in rapid lymphocyte recap-
ture after detachment from the endothelium. This phe-
nomenon may be of even greater significance in condi-
tions of high arterial shear stress. In vivo observations of
arterioles within the dorsal windows used in this study
indicated occasional lymphocyte rolling under shear
stress of >10 dyn/cm2 (not shown).
Observations of lymphocyte-endothelial interaction after
TNF-a activation in this system represent a maximum re-
sponse to a high concentration of cytokine at 5 to 6 h after
stimulation. Thus, the presence of both high selectin and 131
integrin levels may promote some overlap in adhesive roles
at intermediate levels of shear stress, especially in the pres-
ence of RBCs, which may not be as significant with other
activating agents or for different incubation periods. This
potential functional overlap in mediating the initial adhesive
contact of lymphocytes with activated endothelium remains
to be defined in terms of shear stress binding thresholds.
However, earlier in the activation process, before increased
integrin expression, the selectins may be more critical to the
cyte interaction with the vessel walls, followed by selectin-
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lymphocyte localization process (Yan et al., 1994).
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